pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 7·1 min read
save

Boston-born biotech founder Felix Wong launches AI-driven startup in California

Aug 7, 2026·read at STAT ↗Neutral

Felix Wong grew up near Boston, earned two degrees at Harvard and completed a post-doc at MIT before launching his biotech company in California.

His startup applies artificial intelligence to identify compounds that could slow aging, a goal Wong describes as searching for the fountain of youth.

Wong cites California’s creative atmosphere and lower cost pressures compared with Boston’s rising taxes and living expenses as reasons for locating his office in Redwood City.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?”

read at STAT ↗
406 words · retrieved Aug 7
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING2Moderna, Inc.SUNNY
topics
Vaccine2CardiologyHeart FailureMelanomamRNA TherapeuticmRNA Vaccine

related stories

  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 6STAT+: FDA approves Replimune melanoma drug previously rejected twiceSTAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • 5h agoBMS says goodbye to 265 New Jersey staff as reorg rolls onBioSpace
  • Aug 31STAT+: After a rough stretch, mRNA gets a boost — at least for nowSTAT